Clinic for Gynecology and Obstetrics Narodni Front, Belgrade, Serbia.
Faculty of Medicine, University of Belgrade, Belgrade, Serbia.
Medicine (Baltimore). 2024 Aug 2;103(31):e38949. doi: 10.1097/MD.0000000000038949.
Concurrent global increase of prevalence of obesity and male fertility implies link between overweight and obesity with male subfertility. This hypothesis is supported by numerous population-based epidemiological studies. Increase in body mass index (BMI) is associated with poor sperm quality in fertile, and more noticeable in infertile men. Nevertheless, some studies disprove damaging effect of BMI on semen quality. To examine the influence of men's BMI in infertile couples undergoing in vitro fertilization (IVF) on semen analysis parameters and IVF outcomes. Study encompassed all couples who underwent IVF at Gynecology and Obstetrics Clinic Narodni Front in Belgrade during 2018 and 2019. Exclusion criteria were azoospermia, conditions and diseases that could affect the semen analysis parameters (diabetes, malignant diseases treated with radiation and/or chemotherapy, trauma or surgery of the genital organs, mumps or undescended testicles in childhood). Evaluated semen analysis parameters included semen ejaculate volume, sperm pH, sperm count, sperm motility, and sperm morphology. IVF outcomes comprised total number of embryos, number and percentage of obtained good-quality embryos and clinical pregnancy rates. Based on BMI value, participants were divided into a group of underweight (Group 1), normally weight (Group 2), overweight (Group 3), and obese men (Group 4). After applying inclusion and exclusion criteria, 411 men (couples) were included in the analysis. The largest number of men were overweight, while the smallest belonged to the group of underweight participants. There are no significant differences in the semen analysis parameters between study groups. Correlation analysis shown weak and insignificant correlation between BMI and semen analysis parameters. The number and proportion of good quality embryos is significantly lower in overweight and obese study groups compared to normal weight and underweight groups (2.89, 2.91, 2.42, and 2.36, respectively, P = .041). The differences in other IVF outcomes: total number of embryos (3.61, 3.74, 3.21, and 3.37, respectively) and clinical pregnancy rates (41.26%, 43.09%, 42.78%, and 39.95%, respectively) between study groups were not significant (P > .05). BMI does not significantly affect semen analysis parameters, but a higher BMI is associated with a lower number and proportion of good quality embryos in IVF outcomes.
同时,全球肥胖和男性生育力的患病率都在增加,这意味着超重和肥胖与男性生育力低下之间存在关联。这一假设得到了大量基于人群的流行病学研究的支持。体重指数(BMI)的增加与生育能力正常的男性的精子质量差有关,而在不育男性中则更为明显。然而,一些研究反驳了 BMI 对精液质量的有害影响。本研究旨在探讨不育夫妇接受体外受精(IVF)时男性 BMI 对精液分析参数和 IVF 结局的影响。研究包括 2018 年和 2019 年在贝尔格莱德的妇产科诊所 Narodni Front 接受 IVF 的所有夫妇。排除标准为无精子症、可能影响精液分析参数的疾病(糖尿病、接受放疗和/或化疗的恶性疾病、生殖器器官创伤或手术、腮腺炎或儿童期未降睾丸)。评估的精液分析参数包括精液量、精子 pH 值、精子计数、精子活力和精子形态。IVF 结果包括胚胎总数、获得的优质胚胎数量和百分比以及临床妊娠率。根据 BMI 值,参与者分为消瘦组(第 1 组)、正常体重组(第 2 组)、超重组(第 3 组)和肥胖组(第 4 组)。在应用纳入和排除标准后,411 名男性(夫妇)被纳入分析。超重男性的数量最多,而消瘦组的男性数量最少。研究组之间的精液分析参数无显著差异。相关性分析显示,BMI 与精液分析参数之间存在微弱且无统计学意义的相关性。与正常体重和消瘦组相比,超重和肥胖组的优质胚胎数量和比例明显较低(分别为 2.89、2.91、2.42 和 2.36,P=0.041)。其他 IVF 结果的差异:胚胎总数(分别为 3.61、3.74、3.21 和 3.37)和临床妊娠率(分别为 41.26%、43.09%、42.78%和 39.95%)在研究组之间无显著差异(P>0.05)。BMI 对精液分析参数没有显著影响,但 BMI 较高与 IVF 结局中优质胚胎数量和比例较低有关。